Iverlast 12 Tablet contains Ivermectin 12 mg, an antiparasitic agent used for the treatment of various parasitic infections. Ivermectin acts by binding selectively to glutamate-gated chloride ion channels in the nerve and muscle cells of parasites, leading to increased permeability to chloride ions, hyperpolarization, paralysis, and eventual death of the parasite. It is commonly prescribed for conditions such as strongyloidiasis, onchocerciasis, and other nematode infections. Iverlast 12 is effective against a broad spectrum of parasites, including roundworms, threadworms, and certain external parasites. The tablet is administered orally, with dosage depending on the type and severity of infection, as well as patient weight and clinical response. It is generally well tolerated; however, common side effects may include dizziness, nausea, diarrhea, and mild skin rash. Caution is advised in patients with hypersensitivity to ivermectin or those with severe hepatic impairment. Iverlast 12 should be used under medical supervision, especially in pediatric, pregnant, or lactating patients. Proper diagnosis and adherence to prescribed dosage are essential to ensure efficacy and minimize adverse effects. This medication should not be used as a prophylactic agent and is intended solely for the treatment of confirmed parasitic infections.